Gene Therapy Trial at the Retina Foundation of the Southwest featured in The Dallas Morning News
Mason Two Crow, 22, first came to the Retina Foundation in 2003 with a diagnosis of X-linked retinoschisis, a rare genetic condition affecting the retina. Two years ago he came in for a follow-up appointment where he learned that he had the opportunity to be one of the very first to ever be enrolled in a gene therapy trial for his rare eye disease. Mason gives credit to the research scientists at the Retina Foundation for gifting him with the hope that a cure for X-linked retinoschisis may be on the horizon. Click here to read more of Mason’s incredible story on www.dallasnews.com.
Related ArticlesHonoring Dr. Albert Vaiser, Co-Founder of the Retina Foundation 9th Annual David R. Stager Sr., M.D. Lecture Transforming the Future Of Medicine: Retina Foundation Showcases Collaboration with Southern Methodist University and Balanced Media | Technology Watching Movies Could Help Treat Children with Lazy Eye The Edward C. Fogg, III and Lisbeth A. Fogg Charitable Trust grants Retina Foundation $133,000 for Genetic Eye Disease